Figure EV3. Flow cytometry gating strategy.
The gating strategy employed for the in vivo experiment. (A) NK cells were distinguished from the target PANC-1 cells according to FSC and SSC. CD45 (antibody specifically recognizing human (h)CD45) expression was used to further distinguish the pNK from the tumor and any other murine cells. Pseudocolor presentation is shown to identify the NK cells, which are CD45+ (95.9%) referred as tumor infiltrating NK cells (TINK). (B) Flow cytometry analysis of intracellular staining was performed to measure pNK expression on cells from the mice with tumor-only (no NK administration) control and distinguished based on CD45 expression. The NK cells were distinguished from the target cells based on their volume and density (FSC and SSC) and were re-gated to CD45+ subsets. DGKα and Egr2 expressions were measured on the CD45+ gated population. Histogram offsets and MFI were used for graphical presentation. Graphs show fluorescence intensity. The Y axis indicates relative cell number, and the X axis indicates the MFI. (C) Representative histograms and contour plots including outliers for the data in Fig. 3C–F.